US Bancorp DE Sells 3,251 Shares of Cigna Group $CI

US Bancorp DE trimmed its position in shares of Cigna Group (NYSE:CI) by 3.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 94,556 shares of the health services provider’s stock after selling 3,251 shares during the period. US Bancorp DE’s holdings in Cigna Group were worth $26,025,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the company. W.G. Shaheen & Associates DBA Whitney & Co grew its holdings in Cigna Group by 0.3% during the 4th quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 52,252 shares of the health services provider’s stock valued at $14,381,000 after purchasing an additional 151 shares during the last quarter. Interchange Capital Partners LLC bought a new position in Cigna Group during the 4th quarter valued at about $216,000. Wealthfront Advisers LLC grew its holdings in Cigna Group by 56.2% during the 4th quarter. Wealthfront Advisers LLC now owns 47,661 shares of the health services provider’s stock valued at $13,118,000 after purchasing an additional 17,154 shares during the last quarter. Torren Management LLC bought a new position in Cigna Group during the 4th quarter valued at about $105,000. Finally, Ashton Thomas Private Wealth LLC grew its holdings in Cigna Group by 2.5% during the 4th quarter. Ashton Thomas Private Wealth LLC now owns 3,158 shares of the health services provider’s stock valued at $869,000 after purchasing an additional 76 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Trading Down 2.6%

Shares of NYSE CI opened at $283.14 on Friday. The company has a quick ratio of 0.74, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The business has a fifty day simple moving average of $274.34 and a two-hundred day simple moving average of $276.94. The firm has a market cap of $74.62 billion, a PE ratio of 12.77, a price-to-earnings-growth ratio of 1.01 and a beta of 0.26. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.Cigna Group’s revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the company posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Analysts expect that Cigna Group will post 30.35 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be paid a dividend of $1.56 per share. The ex-dividend date is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 28.13%.

Key Headlines Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna reported Q1 results that beat revenue and most EPS expectations, driven by strong Evernorth performance; management raised 2026 adjusted EPS guidance to at least $30.35, supporting upside to valuation. Read More.
• Positive Sentiment: Royal Bank of Canada raised its price target to $337 and kept an “outperform” rating — the move signals bull case support and implies ~19% upside from current levels. Read More.
• Positive Sentiment: Wells Fargo nudged its target to $305 (equal?weight), a modest endorsement that adds to recent analyst support and narrows downside concerns. Read More.
• Neutral Sentiment: Analyst/think?piece commentary frames the Q1 beat and Evernorth growth as a case for a higher multiple; these discussions may influence longer?term sentiment but are not immediate catalysts. Read More.
• Negative Sentiment: Cigna announced it will exit the Affordable Care Act (individual exchange) business in 2027, affecting roughly 369,000 members — the move reduces topline exposure and creates short?term execution and transition risk. Read More.
• Negative Sentiment: Pharmacy/PBM dynamics remain a watch item: rising pharmacy costs and PBM complexity were highlighted in coverage as potential margin pressure even as Evernorth grows — a risk to future earnings momentum. Read More.
• Negative Sentiment: Some data points are mixed (small EPS/estimate variances reported by some sources) and Quiver/other trackers show notable institutional repositioning and some insider sales in recent periods — data investors watch as a potential signal of rebalancing. Read More.

Insider Buying and Selling

In other news, insider Everett Neville sold 1,719 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the transaction, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

CI has been the topic of several analyst reports. Leerink Partners upped their price target on shares of Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a report on Friday, February 6th. Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. Royal Bank Of Canada upped their price target on shares of Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a report on Friday. Sanford C. Bernstein upgraded shares of Cigna Group from a “market perform” rating to an “outperform” rating and upped their target price for the stock from $307.00 to $358.00 in a research note on Thursday, March 12th. Finally, Raymond James Financial set a $340.00 target price on shares of Cigna Group in a research note on Friday. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $336.20.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.